| Report ID | 271635 |
| Drug Identification Number | 01940414 |
| Brand name | VOLTAREN OPHTHA |
| Common or Proper name | VOLTAREN OPH. 0.1% SOLN. 5ML |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DICLOFENAC SODIUM |
| Strength(s) | 0.1% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 5ML |
| Anatomical Therapeutical Chemical (ATC) code | S01BC |
| Anatomical Therapeutical Chemical (ATC) description | ANTIINFLAMMATORY AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2025-11-30 |
| Actual discontinuation date | 2025-11-07 |
| Remaining supply date | 2026-04-30 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | [email protected] |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-11-12 | French | Compare |
| v1 | 2025-11-12 | English | Compare |
Showing 1 to 2 of 2